Sajedi Vahid, Movahedi Masoud, Aghamohammadi Asghar, Gharagozlou Mohammad, Shafiei Alireza, Soheili Habib, Sanajian Nahal
Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Allergy Asthma Immunol. 2011 Jun;10(2):111-7.
Intradermal injection of autologous serum and plasma elicit a cutaneous reactivity in almost 45-60% of patients with Chronic Idiopathic Urticaria (CIU). This reactivity is associated with the presence of auto antibodies against IgE or IgE receptors. This study was carried out to compare the cutaneous reactivity of autologous serum and plasma skin tests in a series of patients with CIU for diagnosis of auto antibodies against IgE or IgE receptor. Fifty eight patients with CIU were injected intradermally with autologous serum and plasma (anticoagulated by citrate). Histamine was used as positive control and normal saline as negative control. The study group was checked by routine laboratory tests (CBC, U/A etc), allergens with skin prick tests, and serum IgE level, and auto antibodies against thyroid as well. Duration of urticaria was another factor which was assessed.There was no significant difference between positive ASST and positive APST patients for the above mentioned tests. 77.6% of the patients were Positive for APST and 65.5% were ASST positive. Duration of urticaria was longer in patients with positive ASST and APST than ASST and APST negative patients, although the difference was not statistically significant.Autologus serum skin test (ASST) and autologous plasma skin test (APST) could be used for estimation of duration and severity of urticaria and planning for the treatment.
皮内注射自体血清和血浆会使近45%-60%的慢性特发性荨麻疹(CIU)患者产生皮肤反应性。这种反应性与抗IgE或IgE受体自身抗体的存在有关。本研究旨在比较一系列CIU患者自体血清皮肤试验和自体血浆皮肤试验的皮肤反应性,以诊断抗IgE或IgE受体的自身抗体。58例CIU患者皮内注射自体血清和血浆(用柠檬酸盐抗凝)。组胺用作阳性对照,生理盐水用作阴性对照。研究组进行了常规实验室检查(血常规、尿常规等)、皮肤点刺试验检测过敏原、血清IgE水平以及抗甲状腺自身抗体检测。荨麻疹病程是另一个评估因素。上述检查中,自体血清皮肤试验(ASST)阳性患者和自体血浆皮肤试验(APST)阳性患者之间无显著差异。77.6%的患者APST呈阳性,65.5%的患者ASST呈阳性。ASST和APST阳性患者的荨麻疹病程比ASST和APST阴性患者更长,尽管差异无统计学意义。自体血清皮肤试验(ASST)和自体血浆皮肤试验(APST)可用于评估荨麻疹的病程和严重程度以及制定治疗方案。